Hainan Huluwa Pharmaceutical Group Co.,Ltd.’s Net Profit Rose 15.9% in First Three Quarters of 2023

Hainan Huluwa Pharmaceutical Group Co.,Ltd. (海南葫芦娃药业集团股份有限公司) (605199.SH) reported a net profit of 82.8 million yuan in the first three quarters of 2023, up 15.9% year-on-year.

Meanwhile, the company posted 1.3 billion yuan in revenue, up 21% year-on-year.

At the end of the reporting period, it had 2.7 billion yuan in total assets and 1.5 billion yuan in total liabilities, with a liability-to-asset ratio of 57.3%.